CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 82 filers reported holding CATALYST BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,936 | +328.3% | 4,017 | +212.6% | 0.00% | – |
| Q2 2023 | $452 | – | 1,285 | -6.7% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 1,377 | -1.2% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 1,394 | -32.9% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 2,076 | +75.3% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 1,184 | -62.7% | 0.00% | – |
| Q1 2022 | $2,000 | -85.7% | 3,175 | +15.5% | 0.00% | – |
| Q1 2021 | $14,000 | 0.0% | 2,748 | +22.8% | 0.00% | – |
| Q4 2020 | $14,000 | -82.3% | 2,238 | -87.8% | 0.00% | -100.0% |
| Q3 2020 | $79,000 | +19.7% | 18,326 | +61.9% | 0.00% | -66.7% |
| Q2 2020 | $66,000 | +725.0% | 11,322 | +585.8% | 0.00% | – |
| Q1 2020 | $8,000 | -55.6% | 1,651 | -38.6% | 0.00% | -100.0% |
| Q4 2019 | $18,000 | – | 2,688 | +3062.4% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 85 | -97.9% | 0.00% | -100.0% |
| Q2 2019 | $29,000 | +2800.0% | 4,037 | +2288.8% | 0.00% | – |
| Q1 2019 | $1,000 | -90.0% | 169 | -81.8% | 0.00% | -100.0% |
| Q3 2018 | $10,000 | +150.0% | 931 | +148.9% | 0.00% | – |
| Q2 2018 | $4,000 | – | 374 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 66,951 | $13,859 | 0.01% |
| Colorado Capital Management, Inc. | 34,165 | $7 | 0.01% |
| Nantahala Capital Management | 160,430 | $33,209 | 0.00% |
| Kynam Capital Management, LP | 89,886 | $18,606 | 0.00% |
| Keebeck Wealth Management, LLC | 20,000 | $4,140 | 0.00% |
| MORGAN STANLEY | 38,404 | $7,950 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 259,467 | $52 | 0.00% |
| BlackRock Inc. | 169,904 | $35,170 | 0.00% |
| Bank of New York Mellon Corp | 200,638 | $41,532 | 0.00% |
| Citadel Advisors | 5,700 | $1,180 | 0.00% |